Jasmine S. Sukumar

Oncology

1515 Holcombe Blvd
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline Update.

Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline Update.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 16, 2026

Weight Loss Patterns and Clinical Outcomes of GLP1 Receptor Agonists in Breast Cancer Survivors.

Weight Loss Patterns and Clinical Outcomes of GLP1 Receptor Agonists in Breast Cancer Survivors.

Journal: Cancer research communications

Published: October 27, 2025

Weight Loss Patterns and Clinical Outcomes of GLP1 Receptor Agonists in Breast Cancer Survivors.

Weight Loss Patterns and Clinical Outcomes of GLP1 Receptor Agonists in Breast Cancer Survivors.

Journal: Cancer research communications

Published: October 27, 2025

Racial and demographic disparities in glp-1ra use among breast cancer patients with Type 2 Diabetes.

Racial and demographic disparities in glp-1ra use among breast cancer patients with Type 2 Diabetes.

Journal: NPJ breast cancer

Published: June 16, 2025

Chronic chemotherapy-induced peripheral neuropathy: living with neuropathy during and after cancer treatments.

Chronic chemotherapy-induced peripheral neuropathy: living with neuropathy during and after cancer treatments.

Journal: Annals of palliative medicine

Published: October 23, 2024

Real-World Immune-Related Adverse Events in Patients With Early Triple-Negative Breast Cancer Who Received Pembrolizumab.

Real-World Immune-Related Adverse Events in Patients With Early Triple-Negative Breast Cancer Who Received Pembrolizumab.

Journal: JCO oncology practice

Published: October 10, 2024

Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer.

Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer.

Journal: Cancer medicine

Published: February 01, 2024

Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls.

Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls.

Journal: Breast (Edinburgh, Scotland)

Published: August 15, 2023

Linking social and built environmental factors to leisure-time physical activity in rural cancer survivors.

Linking social and built environmental factors to leisure-time physical activity in rural cancer survivors.

Journal: Journal of the National Cancer Institute. Monographs

Published: October 24, 2022

Embedding lifestyle interventions into cancer care: has telehealth narrowed the equity gap?

Embedding lifestyle interventions into cancer care: has telehealth narrowed the equity gap?

Journal: Journal of the National Cancer Institute. Monographs

Published: October 04, 2022

Delay Discounting as a Potential Therapeutic Target for Weight Loss in Breast Cancer Survivors.

Delay Discounting as a Potential Therapeutic Target for Weight Loss in Breast Cancer Survivors.

Journal: Cancers

Published: January 03, 2022

Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer.

Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer.

Journal: Breast cancer research and treatment

Published: May 18, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026